Gaush Meditech Ltd (HKG:2407)
Hong Kong · Delayed Price · Currency is HKD 8.70
-0.20 (-2.25%)
Nov 19, 2025, 4:08 PM HKT
Gaush Meditech Revenue
Gaush Meditech had revenue of 653.08M CNY in the half year ending June 30, 2025, a decrease of -6.80%. This brings the company's revenue in the last twelve months to 1.44B, up 6.82% year-over-year. In the year 2024, Gaush Meditech had annual revenue of 1.43B with 1.58% growth.
Revenue (ttm)
1.44B CNY
Revenue Growth
+6.82%
P/S Ratio
0.82
Revenue / Employee
1.63M CNY
Employees
884
Market Cap
1.29B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.43B | 22.16M | 1.58% |
| Dec 31, 2023 | 1.41B | 152.45M | 12.16% |
| Dec 31, 2022 | 1.25B | -44.43M | -3.42% |
| Dec 31, 2021 | 1.30B | 336.14M | 34.94% |
| Dec 31, 2020 | 962.08M | -144.58M | -13.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.89B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |